Hypothalamic digoxin-mediated model for Parkinson's disease

International Journal of Neuroscience

Volumn 113, Issue 4, 2003, Pages 515-536

  Kurup, Ravi Kumar ^a   Kurup, Parameswara Achutha ^b,c  

^a Medical College Hospital Thiruvananthapuram   (India)

^b Metabolic Disorders Research Center   (India)

^c North of Cliff House   (India)

Author keywords

Digoxin; Dolichol; Membrane Na+ K+ ATPase; Parkinson's disease

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); ADENOSINE TRIPHOSPHATE; ALPHA TOCOPHEROL; CARBOHYDRATE; CERULOPLASMIN; CHOLESTEROL; CHONDROITIN SULFATE; DIGOXIN; FATTY ACID; FREE RADICAL; GLUTATHIONE; GLYCOPROTEIN; GLYCOSAMINOGLYCAN; GLYCOSIDASE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYALURONIC ACID; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE; IRON; ISOPRENOID; LYSOSOME ENZYME; MAGNESIUM; NICOTINE; NITRIC OXIDE; QUINOLINIC ACID; SCAVENGER; SEROTONIN; STRYCHNINE; TRYPTOPHAN; TYROSINE; UBIQUINONE;

ADULT; AGED; ARTICLE; BRAIN FUNCTION; CATABOLISM; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE MODEL; ENZYME ACTIVITY; ERYTHROCYTE MEMBRANE; FEMALE; HUMAN; HYPOTHALAMUS; IRON BINDING CAPACITY; LIPID PEROXIDATION; MALE; OXIDATIVE STRESS; PARKINSON DISEASE; PATHOGENESIS; TRYPTOPHAN METABOLISM;

AGED; DIGOXIN; DOLICHOL; ENZYME INHIBITORS; ERYTHROCYTES; FEMALE; GLYCOCONJUGATES; GLYCOSAMINOGLYCANS; HUMANS; HYDROXYMETHYLGLUTARYL COA REDUCTASES; HYPOTHALAMUS; MALE; MEMBRANE PROTEINS; MIDDLE AGED; MODELS, BIOLOGICAL; NA(+)-K(+)-EXCHANGING ATPASE; NEURONS; PARKINSON DISEASE; POLYISOPRENYL PHOSPHATES; TRYPTOPHAN; TYROSINE; UBIQUINONE;

EID: 0038066927     PISSN: 00207454     EISSN: None     Source Type: Journal    
DOI: 10.1080/00207450390162263     Document Type: Article

References (61)

1. Aminoff, M. J. (1972). Neuroacanthocytosis. Brain, 95, 749-760.
2. Arun, P., Ravikumar, A., Leelamma, S., & Kurup, P. A. (1998a). Identification and estimation of endogenous digoxin biological fluids and tissues by TLC and HPLC. Indian Journal of Biochemistry and Biophysics, 35, 308-312.
3. Arun, P., Ravikumar, A., Leelamma, S., & Kurup, P. A. (1998b). Endogenous alkaloids in the brain of rats loaded with tyrosine/tryptophan in the serum of patients of neurodegenerative and psychiatric disorders. Indian Journal of Medical Research, 107, 231-238.
4. Asbkenazi, A., & Dixit, V. M. (1998). Death receptors signaling and modulation. Science, 281, 1305-1308.
5. Beal, F. (1992). Does impairment of energy metabolism result in excitotoxicity neuronal death in neurodegenerative disease. Annals of Neurology, 31, 119-130.
6. Beutler, E., Duran, O., & Kelley, B. M. (1963). Modified procedure for the estimation reduced glutathione. Journal of Laboratory and Clinical Medicine, 61, 882.
7. Beyreuther, K., & Masters, C. L. (1996). Alzheimer's disease-tangle disentanglement. Nature, 383, 476-477.
8. Bloxam, D. L., & Warren, W. H. (1974). Error in the determination of tryptophan by the method of Denkala and Dewey. A revised procedure. Analytical Biochemistry, 60, 621-625.
9. Brien, P. J. O. (1969). Estimation of conjugated dienes and hydroperoxide. Canadian Journal of Biochemistry, 47, 485.
10. Camilli, P. D. (1995). Neurotransmission keeping synapses up to speed. Nature, 375, 450-451.
11. Choi, D. W. (1988). RBC membrane glutamate uptake in motor neuron disease. Neuron, 1, 623-624.
12. Cohn, G., Rammel, A., Cunlifee, B., & Keiboom, A. J. (1983). Determination of alpha tocopherol in biological specimens by high performance liquid chromatography. Journal of Liquid Chromatography, 6, 1123.
13. Curzon, G., & Green, A. R. (1970). Rapid method for the determination of 5-hydroxy tryptamine and 5-hydroxy indoleacetic acid in certain regions of rat brain. British Journal of Pharmacology, 39, 653-655.
14. Edlund, C., Soderberg, M., Kristeenssonm, K., & Dailner, G. (1992). Ubiquinone, dolichol and cholesterol metabolism in aging and Alzheimer's disease. Biochemistry & Cell Biology, 70(6), 422-428.
15. Falholt. K., Lund, B., & Falholt, W. (1973). Estimation of free fatty acids. Clinical Chemica Acta, 46, 105.
16. Finkel, T. H. (1991). T-cell development and transmembrane signaling. Changing biological responses through a unchanging receptor. Immunology Today, 12, 79-86.
17. Gahor, G., & Allon, N. (1994). Spectrofluorometric method for NO determination. Analytical Biochemistry, 220, 16.
18. Goldstein, J. L., & Brown, M. S. (1990). Regulation of the mevalonate pathway. Nature, 343, 425-430.
19. 2+ accumulation in rat striatum and substantia nigra after an intrastriatal injection of quinolinic acid. Experimental Neurology, 121(2), 261-269.
20. Green, R. D., & Reed, C. J. (1998). Mitochondria and apoptosis. Science, 281, 1309-1316.
21. Greenamyre, J. T., & Poter, R. H. P. (1994). Anatomy and physiology of glutamate in CNS. Neurology, 44(88), 7-13.
22. + ATPase activity in essential hypertension. Japanese Heart Journal, 33(6), 785-798.
23. Hairsch, E. C., Mouatt, A., Thomassect, M., Agid, J. F., Agid. Y. A., & Graybiel, A. M. (1996). Neurotransmitters in Parkinson's Disease. Neurodegeneration, 5, 197-205.
24. Hardy, J., & Gwinn-Hardy, K. (1998). Genetic classification of primary neurodegenerative disease. Science, 282, 1075-1078.
25. Haupert, G. T. (1989). Sodium pump regulation by endogenous inhibition. Topics in Membrane Transport, 34, 345-348.
26. Henry, R. J., Chiamori, N., Jacobs, S. L., & Segalov, M. (1960). Estimation of ceruloplasmin. Proceedings of the Society of Experimental Biology and Medicine, 104, 620.
27. Hisaka, A., Kasarnatu, S., & Takenaga, N. (1990). Absorption of a novel prodrug of DOPA. Drug Metabolism and Disposal, 18, 621.
28. Hoehn, M. M., & Yahr, M. D. (1967). Parkinson's disease and its chemotherapy. Biochemical Pharmacology, 24, 1061-1065.
29. Horn, H. D., & Burns, F. H. (1978). Methods of enzymatic analysis. New York: Academic Press.
30. Huber, S. J., & Cumings, J. L. (1992). Parkinson's disease - neuro behavioural aspects. New York: Oxford University Press.
31. Jacob, R. A. (1994). Nutrition, health and antioxidants. INFORM, 5(11), 1271-1280.
32. Jaya, P., & Kurup, P. A. (1986) Effect of magnesium deficiency on the metabolism of glycosaminoglycans in rats. Journal of Bioscience, 10, 487-497.
33. Kakkar, P., Das, B., & Viswanathan, P. N. (1984). A modified spectrophotometric assay of SOD. Indian Journal of Biochemistry and Biophysics, 21, 130.
34. Knebl, J., DeFazio, P., Clearfield, M. B., Little, L., McConathy, W. J., McPherson, R., & Lacko, A. G. (1964). Plasma lipids and cholesterol esterification in Alzheimer's disease. Mechanics of Ageing and Development, 73(1), 69-77.
35. + ATPase a potentially ubiquitous mechanism contributing to CNS neuropathology. Brain Research Review, 16, 283-600.
36. Linstinsky, J. L., Siegal, G. P., & Listinsky, C. M. (1998). Alpha-L-Fucose, a potentially critical molecule in pathologic process including neoplasia. American Journal of Clinical Pathology, 110, 425-440.
37. Lowenstein, J. M. (1969). Methods in enzymology. New York: Academic Press.
38. Maehly, A. C., & Chance, B. (1971). Methods of biochemical analysis. New York: Inter Science.
39. Manoj, A. J., & Kurup, P. A. (1998). Changes in the glycosaminoglycans and glycoproteins in the rat brain during protein calorie malnutrition. Journal of Clinical Biochemistry and Nutrition, 25, 149-157.
40. McGeer, E. G., & McGeer, P. L. (1994). Neurodegenerative disease. Philadelphia: WB Saunders.
41. Monia, B. P., Ecker, J., & Crooke, S. T. (1990). Ubiquitination enzymes. Biotechnology, 8, 209-215.
42. Mukhopadhyay, C. K., Attieh, Z. K., & Fox, P. L. (1998). Role of ceruloplasmin in cellular iron uptake. Science, 279, 714-717.
43. Olanow, C. W. (1992). Metals and free radicals in neurodegenerative disorders. Annals of Neurology, 32, 2.
44. Paglia, D. E., & Valentine, W. N. (1967). Studies on quantitative and qualitative characterisation of erythrocyte glutathione peroxidase. Journal of Laboratory and Clinical Medicine, 70, 158.
45. Palmer, D. N., Maureen, A. A., & Robert, D. J. (1984). Separation of some neutral lipids by normal phase high performance liquid chromatography on a cyanopropyl column: Ubiquinone, dolichol and cholesterol levels in sheep liver. Analytical Biochemistry, 140, 315-319.
46. Ploegh, H. L. (1998). Viral strategies for immune evasion. Science, 280(10), 248-253.
47. Price, W. J. (1985). Spectrochemical analysis by atomic absorption. New York: John Wiley Sons.
48. Rao, A. V., & Ramakrishnan, S. (1975). Estimation of HMG CoA reductase activity. Clinical Chemistry, 21, 1523-1528.
49. 14C-acetate incorporation into digoxin in rat brain and effect of digoxin administration. Indian Journal of Experimental Biology, 3, 420-426.
50. Rayssiguier, Y. (1981). Lipoprotein metabolism: Importance of magnesium. Magnesium Bulletin, 3, 165-177.
51. Seiden, L. S., & Dykstra, L. A. (1977). Psychopharmacology - a biochemical and behavioural approach. New York: Van Nostrand Reinhold Company.
52. Shoulson, I. (1998). Neurodegeneration. Science, 282, 1072-1074.
53. 10 levels correlate with the activities of complex I and complex II/III in mitochondria from Parkinsonian and non-Parkinsonian subjects. Neurology, 45(2), 344-348.
54. Siegel, R. A. (1998). A lesson from secretory granules. Nature, 394, 428-429.
55. Spencer, K., & Price, C. P. (1977). The determination of serum albumin using bromocresol green. American Journal of Clinical Biochemistry, 14, 105-107.
56. Well-Malherbe, S. R. (1971). Methods of biochemical analysis. New York: Inter Science.
57. Wiedemann, C., & Cockcroft, S. (1998). Vesicular transport. Nature, 394, 426-428.
58. Will, E. D. (1969). Lipid peroxide formation in microsomes - general consideration. Biochemical Journal, 113, 315.
59. Wiedemann, C., & Cockcroft, S. (1998). Vesicular transport. Nature, 394, 426-428.
60. Wong, P. W. K., O'Flynn, M. E., & Inouye, R. (1964). Flourimetric method for tyrosine. Clinical Chemistry, 10, 1098-1100.
61. Wootton, I. D. P. (1964). Estimation of iron binding capacity. Micro-analysis in Medical Biochemistry, 4, 124.